Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun 3;2016(6):CD009586.
doi: 10.1002/14651858.CD009586.pub3.

Systematic screening for the detection of atrial fibrillation

Patrick S Moran  1 , Conor Teljeur, Mairin Ryan, Susan M Smith
Affiliations

Systematic screening for the detection of atrial fibrillation

Patrick S Moran et al. Cochrane Database Syst Rev. .

Abstract

Background: Atrial fibrillation (AF), the most common arrhythmia in clinical practice, is a leading cause of morbidity and mortality. Screening for AF in asymptomatic patients has been proposed as a way of reducing the burden of the disease by detecting people who would benefit from prophylactic anticoagulation therapy before the onset of symptoms. However, for screening to be an effective intervention, it must improve the detection of AF and provide benefit for those detected earlier as a result of screening.

Objectives: This review aims to answer the following questions.Does systematic screening increase the detection of AF compared with routine practice? Which combination of screening population, strategy and test is most effective for detecting AF compared with routine practice? What safety issues and adverse events may be associated with individual screening programmes? How acceptable is the intervention to the target population? What costs are associated with systematic screening for AF?

Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (Ovid) and EMBASE (Ovid) up to 11 November 2015. We searched other relevant research databases, trials registries and websites up to December 2015. We also searched reference lists of identified studies for potentially relevant studies, and we contacted corresponding authors for information about additional published or unpublished studies that may be relevant. We applied no language restrictions.

Selection criteria: Randomised controlled trials comparing screening for AF with routine practice in people 40 years of age and older were eligible. Two review authors (PM and CT) independently selected trials for inclusion.

Data collection and analysis: Two review authors (PM and CT) independently assessed risk of bias and extracted data. We used odds ratios (ORs) and 95% confidence intervals (CIs) to present results for the primary outcome, which is a dichotomous variable. As we identified only one study for inclusion, we performed no meta-analysis. We used the GRADE (Grades of Recommendation, Assessment, Development and Evaluation Working Group) method to assess the quality of the evidence and GRADEPro to create a 'Summary of findings' table.

Main results: One cluster-randomised controlled trial met the inclusion criteria for this review. This study compared systematic screening (by invitation to have an electrocardiogram (ECG)) and opportunistic screening (pulse palpation during a general practitioner (GP) consultation for any reason, followed by an ECG if pulse was irregular) versus routine practice (normal case finding on the basis of clinical presentation) in people 65 years of age or older.Results show that both systematic screening and opportunistic screening of people over 65 years of age are more effective than routine practice (OR 1.57, 95% CI 1.08 to 2.26; and OR 1.58, 95% CI 1.10 to 2.29, respectively; both moderate-quality evidence). We found no difference in the effectiveness of systematic screening and opportunistic screening (OR 0.99, 95% CI 0.72 to 1.37; low-quality evidence). A subgroup analysis found that systematic screening and opportunistic screening were more effective in men (OR 2.68, 95% CI 1.51 to 4.76; and OR 2.33, 95% CI 1.29 to 4.19, respectively) than in women (OR 0.98, 95% CI 0.59 to 1.62; and OR 1.2, 95% CI 0.74 to 1.93, respectively). No adverse events associated with screening were reported.The incremental cost per additional case detected by opportunistic screening was GBP 337, compared with GBP 1514 for systematic screening. All cost estimates were based on data from the single included trial, which was conducted in the UK between 2001 and 2003.

Authors' conclusions: Evidence suggests that systematic screening and opportunistic screening for AF increase the rate of detection of new cases compared with routine practice. Although these approaches have comparable effects on the overall AF diagnosis rate, the cost of systematic screening is significantly greater than the cost of opportunistic screening from the perspective of the health service provider. Few studies have investigated effects of screening in other health systems and in younger age groups; therefore, caution needs to be exercised in relation to transferability of these results beyond the setting and population in which the included study was conducted.Additional research is needed to examine the effectiveness of alternative screening strategies and to investigate the effects of the intervention on risk of stroke for screened versus non-screened populations.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest are reported.

Figures

1
1
Study flow diagram.
2
2
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
1.1
1.1. Analysis
Comparison 1: Detection of new cases of atrial fibrillation versus routine practice, Outcome 1: Systematic screening vs routine practice
1.2
1.2. Analysis
Comparison 1: Detection of new cases of atrial fibrillation versus routine practice, Outcome 2: Opportunistic screening vs routine practice
1.3
1.3. Analysis
Comparison 1: Detection of new cases of atrial fibrillation versus routine practice, Outcome 3: Gender subgroups (systematic)
1.4
1.4. Analysis
Comparison 1: Detection of new cases of atrial fibrillation versus routine practice, Outcome 4: Age subgroups (systematic)
1.5
1.5. Analysis
Comparison 1: Detection of new cases of atrial fibrillation versus routine practice, Outcome 5: Gender subgroups (opportunistic)
1.6
1.6. Analysis
Comparison 1: Detection of new cases of atrial fibrillation versus routine practice, Outcome 6: Age subgroups (opportunistic)
2.1
2.1. Analysis
Comparison 2: Detection of new cases of atrial fibrillation versus other screening, Outcome 1: Systematic vs opportunistic screening
2.2
2.2. Analysis
Comparison 2: Detection of new cases of atrial fibrillation versus other screening, Outcome 2: Gender subgroups
2.3
2.3. Analysis
Comparison 2: Detection of new cases of atrial fibrillation versus other screening, Outcome 3: Age subgroups
See this image and copyright information in PMC

Update of

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Hobbs 2005 {published data only}
    1. Fitzmaurice DA, Hobbs FD, Jowett S, Mant J, Murray ET, Holder R, et al. Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ 2007;335(7616):383. - PMC - PubMed
    1. Hobbs FDR, Fitzmaurice DA, Jowett S, Mant J, Murray E, Bryan S, et al. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technology Assessment 2005;9:40. - PubMed
    1. Mant J, Fitzmaurice DA, Hobbs FD, Jowett S, Murray ET, Holder R, et al. Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial. BMJ 2007;335(7616):380. - PMC - PubMed
    1. Swancutt D, Hobbs R, Fitzmaurice D, Mant J, Murray E, Jowett S, et al. A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732]. BMC Cardiovascular Disorders 2004;4:12. - PMC - PubMed

References to studies excluded from this review

ACTRN12612000406808 {published data only}
    1. Freedman B. Screening Education And Recognition in Community pHarmacies of Atrial Fibrillation to prevent stroke (SEARCH-AF). Australian New Zealand Clinical Trials Registry 2012;Trial Identifier: ACTRN12612000406808.
Baxter 1998 {published data only}
    1. Baxter J, Crabtree L, Hildreth A, Gray C, O'Connell J. Atrial fibrillation. Lancet 1998;352(9143):1858. - PubMed
Bury 2015 {published data only}
    1. Bury G, Swan D, Cullen W, Keane D, Tobin H, Egan M, et al. Screening for atrial fibrillation in general practice: a national, cross-sectional study of an innovative technology. International Journal of Cardiology 2015;178:247-52. - PubMed
Claes 2012 {published data only}
    1. Claes N, Van Laethem C, Goethals M, Goethals P, Mairesse G, Schwagten B, et al. Prevalence of atrial fibrillation in adults participating in a large-scale voluntary screening programme in Belgium. Acta Cardiologica 2012;67(3):273-8. - PubMed
DeRuijter 2008 {published data only}
    1. De Ruijter W, Assendelft WJ, Macfarlane PW, Westendorp RG, Gussekloo J. The additional value of routine electrocardiograms in cardiovascular risk management of older people. Scandinavian Journal of Primary Health Care 2008;26(3):147-53. - PMC - PubMed
Ho 2004 {published data only}
    1. Ho SF, O'Mahony MS, Steward JA, Burr ML, Buchalter M. Left ventricular systolic dysfunction and atrial fibrillation in older people in the community--a need for screening? Age and Ageing 2004;33(5):488-92. - PubMed
Hoefman 2005 {published data only}
    1. Hoefman E, Weert HC, Reitsma JB, Koster RW, Bindels PJ. Diagnostic yield of patient-activated loop recorders for detecting heart rhythm abnormalities in general practice: a randomised clinical trial. Family Practice 2005;22(5):478-84. - PubMed
Johnson 2010 {published data only}
    1. Johnson BJ, Urrutia V. Stroke risk factor screening in an inner city public market - A description of the population - A better target for screening/education efforts. Stroke 2010;41:e200-53.
Maeda 2004 {published data only}
    1. Maeda K, Shimbo T, Fukui T. Cost-effectiveness of a community-based screening programme for chronic atrial fibrillation in Japan. Journal of Medical Screening 2004;11(2):97-102. - PubMed
Marek 2011 {published data only}
    1. Marek J, Bufalino V, Davis J, Marek K, Gami A, Stephan W, et al. Feasibility and findings of large-scale electrocardiographic screening in young adults: data from 32,561 subjects. Heart Rhythm 2011;8(10):1555-9. - PubMed
Morgan 2002 {published data only}
    1. Morgan S, Mant D. Randomised trial of two approaches to screening for atrial fibrillation in UK general practice. The British Journal of General Practice 2002;52(478):373-4, 377-80. - PMC - PubMed
Munschauer 1999 {published data only}
    1. Munschauer FE, Hens MM, Priore RL, Stolarski E, Buffamonte S, Carlin A, et al. Screening for atrial fibrillation in the community: a multicenter validation trial. Journal of Stroke and Cerebrovascular Diseases 1999;8(2):99-103. - PubMed
Somerville 2000 {published data only}
    1. Somerville S, Somerville J, Croft P, Lewis M. Atrial fibrillation: a comparison of methods to identify cases in general practice. The British Journal of General Practice 2000;50(458):727-9. - PMC - PubMed
Sudlow 1998 {published data only}
    1. Sudlow M, Rodgers H, Kenny RA, Thomson R. Identification of patients with atrial fibrillation in general practice: a study of screening methods. BMJ 1998;317(7154):327-8. - PMC - PubMed
Virtanen 2014 {published data only}
    1. Virtanen R, Kryssi V, Vasankari T, Salminen M, Kivela SL, Airaksinen KE. Self-detection of atrial fibrillation in an aged population: the LietoAF Study. European Journal of Preventive Cardiology 2014;21(11):1437-42. - PubMed
Wheeldon 1998 {published data only}
    1. Wheeldon NM, Tayler DI, Anagnostou E, Cook D, Wales C, Oakley GD. Screening for atrial fibrillation in primary care. Heart 1998;79(1):50-5. - PMC - PubMed
Wright 2007 {published data only}
    1. Wright J, Bibby J, Eastham J, Harrison S, McGeorge M, Patterson C, et al. Multifaceted implementation of stroke prevention guidelines in primary care: cluster-randomised evaluation of clinical and cost effectiveness. Quality & Safety in Health Care 2007;16(1):51-9. - PMC - PubMed

References to ongoing studies

NCT01291953 {published and unpublished data}
    1. NCT01291953. Effectiveness of Early Detection of Atrial Fibrillation (FAMDAP). http://www.clinicaltrials.gov/ct2/show/NCT01291953 (accessed 24 January 2013).
NCT01593553 {published data only}
    1. NCT01593553. Systematic ECG Screening for Atrial Fibrillation Among 75 Year Old Subjects in the Region of Stockholm and Halland, Sweden. http://www.clinicaltrials.gov/ct2/show/NCT01593553?term=NCT01593553&... (accessed 24 January 2013).

Additional references

Barratt 2002
    1. Barratt A, Mannes P, Irwig L, Trevena L, Craig J, Rychetnik L. Cancer screening. Journal of Epidemiology and Community Health 2002;56(12):899-902. - PMC - PubMed
Benjamin 1994
    1. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994;271(11):840-4. - PubMed
Benjamin 1998
    1. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98(10):946-52. - PubMed
Bilato 2009
    1. Bilato C, Corti MC, Baggio G, Rampazzo D, Cutolo A, Iliceto S, et al. Prevalence, functional impact and mortality of atrial fibrillation in an older Italian population (from the PRO.V.A Study). American Journal of Cardiology 2009;104:1092-7. - PubMed
Caldwell 2012
    1. Caldwell JC, Borbas Z, Donald A, Clifford A, Bolger L, Black A, et al. Simplified electrocardiogram sampling maintains high diagnostic capability for atrial fibrillation: implications for opportunistic atrial fibrillation screening in primary care. Europace 2012;14(2):191-6. - PubMed
CDC 2001
    1. CDC. Utilization of Ambulatory Medical Care by Women: United States, 1997-98. Series Report 13, No. 149, 2001. http://www.cdc.gov/nchs/data/series/sr_13/sr13_149.pdf (accessed 18 May 2016). - PubMed
Cooke 2006
    1. Cooke G, Doust J, Sanders S. Is pulse palpation helpful in detecting atrial fibrillation? A systematic review. Journal of Family Practice 2006;55(2):130-4. - PubMed
Cullinane 1998
    1. Cullinane M, Wainwright R, Brown A, Monaghan M, Markus HS. Asymptomatic embolization in subjects with atrial fibrillation not taking anticoagulants: a prospective study. Stroke 1998;29(9):1810-5. - PubMed
ESC 2010
    1. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). European Heart Journal 2010;31(19):2369-429. - PubMed
Feinberg 1995
    1. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Archives of Internal Medicine 1995;155(5):469–73. - PubMed
Fitzmaurice 2007
    1. Fitzmaurice DA, Hobbs FD, Jowett S, Mant J, Murray ET, Holder R, et al. Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ 2007;335(7616):383. - PMC - PubMed
Flegel 1987
    1. Flegel KM, Shipley MJ, Rose G. Risk of stroke in non-rheumatic atrial fibrillation [published erratum appears in Lancet 1987;1:878]. Lancet 1987;1:526–9. - PubMed
Fletcher 2005
    1. Fletcher RH, Fletcher SW. Clinical epidemiology: the essentials. Fourth edition. Baltimore, MD: Lippincott Williams & Wilkins, 2005.
Frazier 1990
    1. Frazier TG, Cummings PD. Motivational factors for participation in breast cancer screening. Journal of Cancer Education 1990;5(1):51-4. - PubMed
Freiberg 1997
    1. Friberg J, Buch P, Scharling H, Gadsbphioll N, Jensen GB. Rising rates of hospital admissions for atrial fibrillation. Epidemiology 2003;14:666–72. - PubMed
Friberg 2010
    1. Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. European Heart Journal 2010;31:967-75. - PubMed
Friedemann‐Sanchez 2007
    1. Friedemann-Sánchez G, Griffin JM, Partin MR. Gender differences in colorectal cancer screening barriers and information needs. Health Expectations 2007;10(2):148-60. - PMC - PubMed
Furberg 1994
    1. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). American Journal of Cardiology 1994;74:236–41. - PubMed
Fuster 2006
    1. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of CardiologyCommittee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). Journal of the American College of Cardiology 2006;48:149-246. - PubMed
Go 2001
    1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370–5. - PubMed
Goroll 1995
    1. Goroll AH, May LA, Mulley AG. Primary care medicine. Third edition. Philadelphia: Lippincott, 1995.
Gowd 2012
    1. Gowd BM, Thompson PD. Effect of female sex on cardiac arrhythmias. Cardiology in Review 2012;20(6):297-303. - PubMed
Grogan 1992
    1. Grogan M, Smith HC, Gersh BJ, Wood DL. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. American Journal of Cardiology 1992;69(19):1570-3. - PubMed
Harris 2011
    1. Harris R, Sawaya GF, Moyer VA, Calonge N. Reconsidering the criteria for evaluating proposed screening programs: reflections from 4 current and former members of the U.S. Preventive Services Task Force. Epidemiologic Reviews 2011;33:20-35. - PubMed
Harris 2012
    1. Harris K, Edwards D, Mant J. How can we best detect atrial fibrillation? The Journal of the Royal College of Physicians of Edinburgh 2012;42 Suppl 18:5-22. - PubMed
Hart 2007
    1. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Annals of Internal Medicine 2007;146(12):857-67. - PubMed
Heeringa 2006
    1. Heeringa J, de Kuip DAM, Hofman A, Kors JA, Herpen G, Stricker BHCh, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. European Heart Journal 2006;27:949-53. - PubMed
Higgins 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. ;www.cochrane-handbook.org.
Hohnloser 2007
    1. Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, et al. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. Journal of the American College of Cardiology 2007;50(22):2156-61. - PubMed
Jepson 2000
    1. Jepson R, Clegg A, Forbes C, Lewis R, Sowden A, Kleijnen J. The determinants of screening uptake and interventions for increasing uptake: a systematic review. Health Technology Assessment 2000;4(14):1-133. - PubMed
Kannel 1983
    1. Kannel WB, Abbott RD, Savage DD, McNamara PM. Coronary heart disease and atrial fibrillation: the Framingham Study. American Heart Journal 1983;106:389–96. - PubMed
Krahn 1995
    1. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. American Journal of Medicine 1995;98:476–84. - PubMed
Lefebvre 2011
    1. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S, editors(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
Levy 2003
    1. Levy S, Camm AJ, Saksena S, Aliot E, Breithardt G, Crijns H, et al. International consensus on nomenclature and classification of atrial fibrillation; a collaborative project of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Europace 2003;5:119–22. - PubMed
Lin 1995
    1. Lin HJ, Wolf PA, Benjamin EJ, Belanger AJ, D'Agostino RB. Newly diagnosed atrial fibrillation and acute stroke. The Framingham Study. Stroke 1995;26(9):1527-30. - PubMed
Lin 1996
    1. Lin HJ, Wolf PA, Kelly-Hayes M, Beiser AS, Kase CS, Benjamin EJ, et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke 1996;27:1760-4. - PubMed
Lip 2012
    1. Lip GY, Brechin CM, Lane DA. The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe. Chest 2012;142(6):1489-98. - PubMed
McGregor 2006
    1. McGregor P, Nolan A, Nolan B, O'Neill C. A comparison of GP visiting in Northern Ireland and the Republic of Ireland. ESRI Research Programme on Health Services, Health Inequalities and Health and Social Gain 2006;Working paper No. 22.
NCCCC 2006
    1. National Collaborating Centre for Chronic Conditions. Atrial fibrillation: national clinical guideline for management in primary and secondary care. London: Royal College of Physicians, 2006. - PubMed
Ogilvie 2010
    1. Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. American Journal of Medicine 2010;123(7):638-45. - PubMed
Ott 1997
    1. Ott A, Breteler MM, Bruyne MC, Harskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke 1997;28(2):316-21. - PubMed
Parkin 2008
    1. Parkin DM, Tappenden P, Olsen AH, Patnick J, Sasieni P. Predicting the impact of the screening programme for colorectal cancer in the UK. Journal of Medical Screening 2008;15(4):163-74. - PubMed
Peate 2004
    1. Peate I. Men's attitudes towards health and the implications for nursing care. British Journal of Nursing 2004;13(9):540-5. - PubMed
Psaty 1997
    1. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997;96(7):2455–61. - PubMed
Savelieva 2000
    1. Savelieva I, Camm AC. Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life and management. Journal of Interventional Cardiac Electrophysiology 2000;4:369-82. - PubMed
Stewart 2001
    1. Stewart S, MacIntyre K, MacLeod MM, Bailey AE, Capewell S, McMurray JJ. Trends in hospital activity,morbidity and case fatality related to atrial fibrillation in Scotland,1986–1996. European Heart Journal 2001;22(8):693–701. - PubMed
Stewart 2002
    1. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. American Journal of Medicine 2001;113(5):359-64. - PubMed
Swancutt 2004
    1. Swancutt D, Hobbs R, Fitzmaurice D, Mant J, Murray E, Jowett S, et al. A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732]. BMC Cardiovascular Disorders 2004;4:12. - PMC - PubMed
Wardle 2005
    1. Wardle J, Miles A, Atkin W. Gender differences in utilization of colorectal cancer screening. Journal of Medical Screening 2005;12(1):20-7. - PubMed
Wattigney 2003
    1. Wattigney WA, Mensah GA, Croft JB. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. Circulation 2003;108:711–6. - PubMed
Weller 2009
    1. Weller DP, Campbell C. Uptake in cancer screening programmes: a priority in cancer control. British Journal of Cancer 2009;101 Suppl 2:S55-9. - PMC - PubMed
Wilson Jungner 1968
    1. Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva, Switzerland: World Health Organization, 1968.
Wolf 1983
    1. Wolf PA, Kannel WB, McGee DL, Meeks SL, Bharucha NE, McNamara PM. Duration of atrial fibrillation and imminence of stroke: the Framingham study. Stroke 1983;14(5):664-7. - PubMed
Wolf 1987
    1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Archives of Internal Medicine 1987;147(9):1561-4. - PubMed
Wolf 1991
    1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22(8):983-8. - PubMed
Wyse 2002
    1. Wyse DG, Waldo AL DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. New England Journal of Medicine 2002;347(23):1825-33. - PubMed

Publication types